Acute Effects of vasoactive drug treatment on brachial artery reactivity

被引:55
作者
Gokce, N
Holbrook, M
Hunter, LM
Palmisano, J
Vigalok, E
Keaney, JF
Vita, JA [1 ]
机构
[1] Boston Univ, Sch Med, Evans Dept Med, Cardiol Sect, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA
关键词
D O I
10.1016/S0735-1097(02)02034-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The goal of this study was to investigate whether concomitant therapy with vasoactive medications alters the results of noninvasive assessment of endothelial function. BACKGROUND Ultrasound assessment of brachial artery flow-mediated dilation is emerging as a useful clinical tool. The current practice of withholding cardiac medications before ultrasound studies has unknown utility and would limit the clinical use of the methodology. METHODS To determine whether a single dose of a vasoactive drug influences brachial reactivity, we examined flow-mediated dilation and nitroglycerin-mediated dilation in 73 healthy subjects (age 27 +/- 6 years). Studies were completed at baseline and 3 h after randomized treatment with a single oral dose of placebo, felodipine (5 mg), metoprolol (50 mg), or enalapril (10 mg). To determine if holding vasoactive therapy for 24 It before study yields different results than continuation of clinically prescribed medications, we examined vascular function in 72 patients (age 57 +/- 10 years) with coronary artery disease. Ultrasound studies were performed 24 h after the last dose and again 3 h after patients took their clinically prescribed medications. RESULTS In healthy subjects one dose of all three drugs lowered blood pressure, and metoprolol also lowered heart rate. However, there was no significant effect of treatment on brachial artery dilation. In patients with coronary artery disease on chronic treatment, taking prescribed medications reduced blood pressure and heart rate, but had no significant effect on brachial. artery dilation. CONCLUSIONS Recent administration of commonly used nonnitrate vasoactive drugs has no significant effect on brachial reactivity. These findings suggest that current practice of withholding cardiac medications before testing endothelial function may not be necessary, making this methodology more practical for clinical use. (C) 2002 by the American College of Cardiology Foundation.
引用
收藏
页码:761 / 765
页数:5
相关论文
共 19 条
[1]   Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study) [J].
Anderson, TJ ;
Elstein, E ;
Haber, H ;
Charbonneau, F .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (01) :60-66
[2]  
Benjamin EJ, 2001, CIRCULATION, V104, P152
[3]   Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery - A report of the International Brachial Artery Reactivity Task Force [J].
Corretti, MC ;
Anderson, TJ ;
Benjamin, EJ ;
Celermajer, D ;
Charbonneau, F ;
Creager, MA ;
Deanfield, J ;
Drexler, H ;
Gerhard-Herman, M ;
Herrington, D ;
Vallance, P ;
Vita, J ;
Vogel, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (02) :257-265
[4]   Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease [J].
Duffy, SJ ;
Keaney, JF ;
Holbrook, M ;
Gokce, N ;
Swerdloff, PL ;
Frei, B ;
Vita, JA .
CIRCULATION, 2001, 104 (02) :151-156
[5]   Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease [J].
Gokce, N ;
Keaney, JF ;
Frei, B ;
Holbrook, M ;
Olesiak, M ;
Zachariah, BJ ;
Leeuwenburgh, C ;
Heinecke, JW ;
Vita, JA .
CIRCULATION, 1999, 99 (25) :3234-3240
[6]   Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function - A prospective study [J].
Gokce, N ;
Keaney, JF ;
Hunter, LM ;
Watkins, MT ;
Menzoian, JO ;
Vita, JA .
CIRCULATION, 2002, 105 (13) :1567-1572
[7]   Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease [J].
Heitzer, T ;
Schlinzig, T ;
Krohn, K ;
Meinertz, T ;
Münzel, T .
CIRCULATION, 2001, 104 (22) :2673-2678
[8]   Comparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease - Role of superoxide dismutase [J].
Hornig, B ;
Landmesser, U ;
Kohler, C ;
Ahlersmann, D ;
Spiekermann, S ;
Christoph, A ;
Tatge, H ;
Drexler, H .
CIRCULATION, 2001, 103 (06) :799-805
[9]   Need for standardization of noninvasive assessment of vascular endothelial function [J].
Kuvin, JT ;
Patel, AR ;
Karas, RH .
AMERICAN HEART JOURNAL, 2001, 141 (03) :327-328
[10]   CHOLESTEROL REDUCTION IN CARDIOVASCULAR-DISEASE - CLINICAL BENEFITS AND POSSIBLE MECHANISMS [J].
LEVINE, GN ;
KEANEY, JF ;
VITA, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (08) :512-521